NLIGHT, INC.·4

Mar 11, 7:51 PM ET

Locke Gary 4

4 · NLIGHT, INC. · Filed Mar 11, 2026

Research Summary

AI-generated summary of this filing

Updated

NLIGHT (LASR) Director Gary Locke Exercises 69,725 Options

What Happened

  • Gary Locke, a director of NLIGHT, exercised 69,725 derivative securities (reported as code M) on March 9, 2026, at an exercise price of $1.45 per share, resulting in an acquisition valued at $101,101. The filing also reports a simultaneous disposition of 69,725 derivative units at $0.00 (reported separately).
  • This transaction is an option exercise (an acquisition), not a market sale. The filing does not show a cash sale of the newly acquired shares for proceeds.

Key Details

  • Transaction date: 2026-03-09; Filing date (Form 4): 2026-03-11 (appears timely under the two-business-day rule).
  • Exercise: 69,725 shares @ $1.45 = $101,101 (code M, acquired).
  • Disposition: 69,725 derivative units @ $0.00 = $0 (reported as disposed; filing does not specify reason).
  • Shares owned after transaction: Not specified in the provided excerpt.
  • Footnotes: F1 notes totals include common stock and unvested restricted stock units; F2 states the grant became fully vested and exercisable on Aug 3, 2022.
  • No 10b5-1 plan, late filing flag, or sale-for-proceeds explicitly noted in the provided data.

Context

  • For retail investors: this was an option exercise (insider acquiring stock via conversion of derivatives). The simultaneous disposition at $0.00 often reflects share surrender or withholding to cover exercise costs or tax obligations, but the filing does not state the specific mechanism.
  • Exercises are routine for vested option holders and are not an explicit bullish or bearish signal on their own; they primarily reflect vesting and personal liquidity or tax actions.

Insider Transaction Report

Form 4
Period: 2026-03-09
Locke Gary
Director
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-09$1.45/sh+69,725$101,101112,574 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F2]
    2026-03-0969,7250 total
    Exercise: $1.45Exp: 2027-08-03Common Stock (69,725 underlying)
Footnotes (2)
  • [F1]Includes common stock owned and unvested restricted stock units.
  • [F2]This grant became fully vested and exercisable on Aug 3, 2022.
Signature
/s/ Julie Dimmick, as attorney-in-fact|2026-03-11

Documents

1 file
  • 4
    wk-form4_1773273114.xmlPrimary

    FORM 4